Posts by: Kara Elam

Kara Elam

Kara Elam is currently working on her Doctorate in Health Policy. She holds Master Degrees in both epidemiology and microbiology. Her research interests include emerging viral diseases, the intersection of human rights and intellectual property rights, and ending violence against women.

December 8, 2016December 8, 2016

FDA’s Approval of Avastin for Ovarian Cancer Offers New Hope, Treatment Option

News

The U.S. Food and Drug Administration (FDA) approved Genentech’s Avastin in combination with chemotherapy for the treatment of platinum-sensitive recurrent ovarian cancer (psOC). This marks the first new psOC treatment option ... Read more

July 21, 2016July 21, 2016

Metastasis in Ovarian Cancer Traced to Newly Discovered Signaling Pathway

News

Researchers at Cold Spring Harbor Laboratory (CSHL) published findings that highlight the discovery of a new cancer signaling pathway that may prove useful in the efforts to prevent metastasis in ovarian cancer (OC). ... Read more

July 19, 2016July 19, 2016

Preventive Surgical Procedure for Ovarian Cancer Shows Promise in Large Hospital System

News

A recently published study shows that a system-wide educational program for healthcare providers about the potential of salpingectomy to reduce ovarian cancer risk resulted in a significant increase in the number ... Read more

July 13, 2016July 13, 2016

Researchers Suggest Lowering Guildelines for Pre-emptive Surgery Against Ovarian Cancer

News

UK researchers have recently suggested that the current guidelines for women to receive risk-reducing salpingo-oophorectomy (RRSO) should be re-evaluated in order to allow the cost-effective and lifesaving procedure for women with as little ... Read more